Head of Department
RNDr. Michal Dubovický, CSc.
National
Current
- Experimental real-life risk simulation approach: The effect of long-term exposure to a chemical mixture of pesticides, contaminants and food additives at low doses in extended one-generation reproductive toxicity studyProgram: VEGADuration: 1. 1. 2024 – 31. 12. 2027
- EXPERIMENTAL STUDY OF THE EFFECTS OF MATERNAL DEPRESSION AND ANTIDEPRESSANTS CITALOPRAM AND SERTRALINE ON POSTNATAL DEVELOPMENT OF RAT OFFSPRINGProgram: VEGADuration: 1. 1. 2023 – 31. 12. 2026
- Neuroprotective and cardioprotective potential of phenol acids in the prevention of civilization diseasesProgram: VEGADuration: 1. 1. 2023 – 31. 12. 2026
Finished
- Novel antidepressant therapy - long term consequencies on offspringProgram: SRDADuration: 1. 7. 2020 – 28. 6. 2024
- -Program: VEGADuration: 1. 1. 2020 – 31. 12. 2023
- Prenatal programming of adult diseases: treatment and prevention of outcomes of gestational hypoxia in rat offspringProgram: VEGADuration: 1. 1. 2020 – 31. 12. 2023
- -Program: VEGADuration: 1. 1. 2019 – 31. 12. 2022
- -Program: SRDADuration: 1. 7. 2016 – 30. 6. 2020
- Prenatal and postnatal effects of δ and µ opioid receptor ligands on the hippocampal development and functionProgram: SRDADuration: 1. 7. 2016 – 30. 6. 2020
- Prenatal programming of psychiatric diseases: experimental approaches for evaluation of causes and mechanisms of their originProgram: VEGADuration: 1. 1. 2016 – 31. 12. 2019
- Mechanisms, early detection and therapy of asphyxial injury in perinatal period - comparison of experimental data with clinical observation of asphyxial newbornsProgram: VEGADuration: 1. 1. 2015 – 31. 12. 2018
- Study of consequences of maternal depression and antidepressant venlafaxine treatment on functional development of the brain and behavior of rat offspringProgram: VEGADuration: 1. 1. 2015 – 31. 12. 2018
- -Program:Duration: 1. 9. 2015 – 31. 8. 2018
- Prenatal programming of psychiatric diseases: experimental approaches for evaluation of causes and mechanisms of their originProgram: VEGADuration: 1. 1. 2012 – 31. 12. 2015
- The study of mechanisms and possible early detection of embryofetal damage caused by intrauterine perinatal hypoxiaProgram: VEGADuration: 1. 1. 2011 – 31. 10. 2014
- -Program: VEGADuration: 1. 1. 2011 – 31. 10. 2014
- Early screening of anxiolytic and antidepressive properties of pyridoindole derivativesProgram: VEGADuration: 1. 1. 2009 – 31. 12. 2011
- Experimental models of perinatal asphyxia in evaluation of behavioral disorders and possibility of pharmacological interventionProgram: VEGADuration: 1. 1. 2008 – 31. 12. 2010
- Developmental Origin of Metabolic Syndrome:Hypertension, Diabetes and DyslipidemiaProgram: VEGADuration: 1. 1. 2008 – 31. 12. 2010
- Long-term administration of low dose of L-NAME: Possibility to improve function of vessel wall in border hypertension?Program: VEGADuration: 1. 1. 2007 – 31. 12. 2009
- Long-term low dose L-NAME treatment:Possibility to improve the vascular function in borderline hypertension?Program: VEGADuration: 1. 1. 2007 – 31. 12. 2009
- Molecular mechanisms of new drugs influencing oxidative stress - important ethiopathogenetic factor of numerous diseasesProgram: SRDADuration: 1. 9. 2006 – 31. 10. 2009
- Contribution to prevention and treatment of behavioural disorders evoked by hypotic-ischaemic damage of the brain in perinatal period: experimental model of asphyxia and administration of substances with antiradical and antioxidative effectsProgram: VEGADuration: 1. 1. 2005 – 1. 12. 2007
- Study of neuroprotective action of new pyridoindole antioxidantsProgram: VEGADuration: 1. 1. 2005 – 1. 12. 2007
- The interaction of stress and genetic factors in the etiology of high blood pressure and behavioral failure: the role of nitric oxideProgram: VEGADuration: 1. 1. 2004 – 31. 12. 2006